Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy

Anna Conti, Floriana Fabbrini, Paola D'Agostino, Rosa Negri, Dario Greco, Rita Genesio, Maria D'Armiento, Carlo Olla, Dario Paladini, Mariastella Zannini, Lucio Nitsch

Research output: Contribution to journalArticle

Abstract

Background: The Down syndrome phenotype has been attributed to overexpression of chromosome 21 (Hsa21) genes. However, the expression profile of Hsa21 genes in trisomic human subjects as well as their effects on genes located on different chromosomes are largely unknown. Using oligonucleotide microarrays we compared the gene expression profiles of hearts of human fetuses with and without Hsa21 trisomy. Results: Approximately half of the 15,000 genes examined (87 of the 168 genes on Hsa21) were expressed in the heart at 18-22 weeks of gestation. Hsa21 gene expression was globally upregulated 1.5 fold in trisomic samples. However, not all genes were equally dysregulated and 25 genes were not upregulated at all. Genes located on other chromosomes were also significantly dysregulated. Functional class scoring and gene set enrichment analyses of 473 genes, differentially expressed between trisomic and non-trisomic hearts, revealed downregulation of genes encoding mitochondrial enzymes and upregulation of genes encoding extracellular matrix proteins. There were no significant differences between trisomic fetuses with and without heart defects. Conclusion: We conclude that dosage-dependent upregulation of Hsa21 genes causes dysregulation of the genes responsible for mitochondrial function and for the extracellular matrix organization in the fetal heart of trisomic subjects. These alterations might be harbingers of the heart defects associated with Hsa21 trisomy, which could be based on elusive mechanisms involving genetic variability, environmental factors and/or stochastic events.

Original languageEnglish
Article number268
JournalBMC Genomics
Volume8
DOIs
Publication statusPublished - Aug 7 2007

Fingerprint

Chromosomes, Human, Pair 21
Trisomy
Extracellular Matrix
Fetus
Genes
Mitochondrial Genes
Transcriptome
Up-Regulation
Chromosomes
Fetal Heart
Extracellular Matrix Proteins
Down Syndrome
Oligonucleotide Array Sequence Analysis
Down-Regulation

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. / Conti, Anna; Fabbrini, Floriana; D'Agostino, Paola; Negri, Rosa; Greco, Dario; Genesio, Rita; D'Armiento, Maria; Olla, Carlo; Paladini, Dario; Zannini, Mariastella; Nitsch, Lucio.

In: BMC Genomics, Vol. 8, 268, 07.08.2007.

Research output: Contribution to journalArticle

Conti, A, Fabbrini, F, D'Agostino, P, Negri, R, Greco, D, Genesio, R, D'Armiento, M, Olla, C, Paladini, D, Zannini, M & Nitsch, L 2007, 'Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy', BMC Genomics, vol. 8, 268. https://doi.org/10.1186/1471-2164-8-268
Conti, Anna ; Fabbrini, Floriana ; D'Agostino, Paola ; Negri, Rosa ; Greco, Dario ; Genesio, Rita ; D'Armiento, Maria ; Olla, Carlo ; Paladini, Dario ; Zannini, Mariastella ; Nitsch, Lucio. / Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. In: BMC Genomics. 2007 ; Vol. 8.
@article{b5326cdd99d34fc1ba5f97e23c8268d9,
title = "Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy",
abstract = "Background: The Down syndrome phenotype has been attributed to overexpression of chromosome 21 (Hsa21) genes. However, the expression profile of Hsa21 genes in trisomic human subjects as well as their effects on genes located on different chromosomes are largely unknown. Using oligonucleotide microarrays we compared the gene expression profiles of hearts of human fetuses with and without Hsa21 trisomy. Results: Approximately half of the 15,000 genes examined (87 of the 168 genes on Hsa21) were expressed in the heart at 18-22 weeks of gestation. Hsa21 gene expression was globally upregulated 1.5 fold in trisomic samples. However, not all genes were equally dysregulated and 25 genes were not upregulated at all. Genes located on other chromosomes were also significantly dysregulated. Functional class scoring and gene set enrichment analyses of 473 genes, differentially expressed between trisomic and non-trisomic hearts, revealed downregulation of genes encoding mitochondrial enzymes and upregulation of genes encoding extracellular matrix proteins. There were no significant differences between trisomic fetuses with and without heart defects. Conclusion: We conclude that dosage-dependent upregulation of Hsa21 genes causes dysregulation of the genes responsible for mitochondrial function and for the extracellular matrix organization in the fetal heart of trisomic subjects. These alterations might be harbingers of the heart defects associated with Hsa21 trisomy, which could be based on elusive mechanisms involving genetic variability, environmental factors and/or stochastic events.",
author = "Anna Conti and Floriana Fabbrini and Paola D'Agostino and Rosa Negri and Dario Greco and Rita Genesio and Maria D'Armiento and Carlo Olla and Dario Paladini and Mariastella Zannini and Lucio Nitsch",
year = "2007",
month = "8",
day = "7",
doi = "10.1186/1471-2164-8-268",
language = "English",
volume = "8",
journal = "BMC Genomics",
issn = "1471-2164",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy

AU - Conti, Anna

AU - Fabbrini, Floriana

AU - D'Agostino, Paola

AU - Negri, Rosa

AU - Greco, Dario

AU - Genesio, Rita

AU - D'Armiento, Maria

AU - Olla, Carlo

AU - Paladini, Dario

AU - Zannini, Mariastella

AU - Nitsch, Lucio

PY - 2007/8/7

Y1 - 2007/8/7

N2 - Background: The Down syndrome phenotype has been attributed to overexpression of chromosome 21 (Hsa21) genes. However, the expression profile of Hsa21 genes in trisomic human subjects as well as their effects on genes located on different chromosomes are largely unknown. Using oligonucleotide microarrays we compared the gene expression profiles of hearts of human fetuses with and without Hsa21 trisomy. Results: Approximately half of the 15,000 genes examined (87 of the 168 genes on Hsa21) were expressed in the heart at 18-22 weeks of gestation. Hsa21 gene expression was globally upregulated 1.5 fold in trisomic samples. However, not all genes were equally dysregulated and 25 genes were not upregulated at all. Genes located on other chromosomes were also significantly dysregulated. Functional class scoring and gene set enrichment analyses of 473 genes, differentially expressed between trisomic and non-trisomic hearts, revealed downregulation of genes encoding mitochondrial enzymes and upregulation of genes encoding extracellular matrix proteins. There were no significant differences between trisomic fetuses with and without heart defects. Conclusion: We conclude that dosage-dependent upregulation of Hsa21 genes causes dysregulation of the genes responsible for mitochondrial function and for the extracellular matrix organization in the fetal heart of trisomic subjects. These alterations might be harbingers of the heart defects associated with Hsa21 trisomy, which could be based on elusive mechanisms involving genetic variability, environmental factors and/or stochastic events.

AB - Background: The Down syndrome phenotype has been attributed to overexpression of chromosome 21 (Hsa21) genes. However, the expression profile of Hsa21 genes in trisomic human subjects as well as their effects on genes located on different chromosomes are largely unknown. Using oligonucleotide microarrays we compared the gene expression profiles of hearts of human fetuses with and without Hsa21 trisomy. Results: Approximately half of the 15,000 genes examined (87 of the 168 genes on Hsa21) were expressed in the heart at 18-22 weeks of gestation. Hsa21 gene expression was globally upregulated 1.5 fold in trisomic samples. However, not all genes were equally dysregulated and 25 genes were not upregulated at all. Genes located on other chromosomes were also significantly dysregulated. Functional class scoring and gene set enrichment analyses of 473 genes, differentially expressed between trisomic and non-trisomic hearts, revealed downregulation of genes encoding mitochondrial enzymes and upregulation of genes encoding extracellular matrix proteins. There were no significant differences between trisomic fetuses with and without heart defects. Conclusion: We conclude that dosage-dependent upregulation of Hsa21 genes causes dysregulation of the genes responsible for mitochondrial function and for the extracellular matrix organization in the fetal heart of trisomic subjects. These alterations might be harbingers of the heart defects associated with Hsa21 trisomy, which could be based on elusive mechanisms involving genetic variability, environmental factors and/or stochastic events.

UR - http://www.scopus.com/inward/record.url?scp=34548496286&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548496286&partnerID=8YFLogxK

U2 - 10.1186/1471-2164-8-268

DO - 10.1186/1471-2164-8-268

M3 - Article

C2 - 17683628

AN - SCOPUS:34548496286

VL - 8

JO - BMC Genomics

JF - BMC Genomics

SN - 1471-2164

M1 - 268

ER -